Preventive Maintenance for Reagents Sequencing Services
Looking for contract opportunity help?
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
General Information
- Contract Opportunity Type: Presolicitation (Original)
- Original Published Date: Feb 08, 2022 09:16 am EST
- Original Response Date: Feb 15, 2022 09:00 am EST
- Inactive Policy: Manual
- Original Inactive Date: Feb 16, 2022
- Initiative:
- None
Classification
- Original Set Aside:
- Product Service Code:
- NAICS Code:
- Place of Performance: Bethesda , MDUSA
Description
Solicitation #
HHSNIHOPCSBSS-22-003276
Date Posted 2-8-2022
Date Closed 2-15-2022
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.
The National Institute of Health (NIH), Clinical Center (CC),Depatment of Transfusion Medicine (DTM) intends to solicit a quote and enter into firm-fixed price for preventive maintenance for Sequencing reagents with Illumina INC
Illumina, provides the clinically approved platform for reagents, kits, and the respective instruments that may be used for patient care testing for differential gene expression analysis and tracking immunotherapy efficiency and monitoring side effects on clinical and research cellular products. The preventive maintenance is required to compliance with manufacturer and FDA 21 CFR 211.67. The NextSeq550 sequencer instrument is a unique instrument that can help us identify specific cell populations and modifications to guide and improve cell product administrated to the patient. This instrument is needed to generate data that is required for providing guidance to improve immunotherapy efficiency of the cellular therapy product.
The purpose of this correspondence is to request a PO to purchase Preventive maintenance support for Illumina under citation 10 U.S.C. 2304(c) (2), 41 U.S.C. 253(c) (2) and FAR 6.302-1: Quality of product required for ongoing experiments as well as a Proprietary request/Only One Responsible Source.
This acquisition is being conducted using policies unique to the acquisition of commercial items prescribed in FAR Part 12, in conjunction with the policies and procedures for the competition requirements of Part 6. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.
Comments to this announcement, referencing this posting number, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date, FEB 15,, 2022 at 9:00 EST specified in this announcement, electronically to the attention of Priscilla Abalos, Contract Specialist, Priscilla.abalos@nih.gov by the due date and time marked in this notice.
Attachments/Links
Contact Information
Primary Point of Contact
- Priscilla Abalos
- Priscilla.abalos@nih.gov
- Phone Number 3015945918